Cargando…
Biomarkers for colitis-associated colorectal cancer
Patients with extensive ulcerative colitis (UC) of more than eight years duration have an increased risk of colorectal cancer. Molecular biomarkers for dysplasia and cancer could have a great clinical value in managing cancer risk in these UC patients. Using a wide range of molecular techniques - in...
Autores principales: | Chen, Ru, Lai, Lisa A, Brentnall, Teresa A, Pan, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028804/ https://www.ncbi.nlm.nih.gov/pubmed/27672285 http://dx.doi.org/10.3748/wjg.v22.i35.7882 |
Ejemplares similares
-
Glycoproteins and glycoproteomics in pancreatic cancer
por: Pan, Sheng, et al.
Publicado: (2016) -
Arousal of Cancer-Associated Stroma: Overexpression of Palladin Activates Fibroblasts to Promote Tumor Invasion
por: Brentnall, Teresa A., et al.
Publicado: (2012) -
Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020) -
The role of autophagy in colitis-associated colorectal cancer
por: Wu, Yuhui, et al.
Publicado: (2018) -
The Role of Dyslipidemia in Colitis-Associated Colorectal Cancer
por: Chen, Ke, et al.
Publicado: (2021)